NCT02937831View on ClinicalTrials.gov

RIXUBIS Drug Use-Result Survey (Japan)

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

November 16, 2016

Primary Completion Date

May 11, 2022

Study Completion Date

May 11, 2022

Conditions
Hemophilia B
Interventions
BIOLOGICAL

RIXUBIS

Trial Locations (5)

501-3802

Seki-shi, Japan, Seki-shi

371-8511

Maebashi-shi, Japan, Maebashi

882-0835

Nobeoka-shi, Japan, Nobeoka-shi

950-0862

Niigata-shi, Japan, Niigata

543-0001

Osaka-shi, Japan, Osaka

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

Baxalta now part of Shire

INDUSTRY